ClinVar Miner

Submissions for variant NM_000517.6(HBA2):c.89T>C (p.Leu30Pro)

dbSNP: rs41341344
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000759059 SCV000888140 pathogenic not provided 2022-10-27 criteria provided, single submitter clinical testing The c.89T>C (p.Leu30Pro) mutation in the alpha2-globin gene is known as Hb Agrinio. Hb Agrinio is reported as being hyperunstable. Individuals who are heterozygous for this variant are reported as having a normal clinical presentation (PMID: 8537235 (1995)). However, individuals who are homozygous for this variant, or compound heterozygous for this variant and a mutation associated with alpha-thalassemia, often present with atypical Hb H disease (PMIDs: 36052950 (2022), 29219637 (2017), 23094635 (2012), 22452522 (2012), 20854116 (2010), 9629496 (1998), 8537235 (1995), and 8136277 (1993)).
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000759059 SCV003800217 pathogenic not provided 2022-07-09 criteria provided, single submitter clinical testing The HBA2 c.89T>C; p.Leu30Pro variant (also known as Hb Agrinio or Leu29Pro when numbered from the mature protein, rs41341344, HbVar ID:45) has been reported in multiple individuals with microcytosis and hypochromia when found in a heterozygous state (de la Fuente-Gonzalo 2012, Hall 1993). Individuals homozygous for this variant or compound heterozygous with another pathogenic variant exhibit marked hypochromic microcytic anemia, with an elevated reticulocyte count and occasionally elevated Hb Barts or Hb H (de la Fuente-Gonzalo 2012, Hall 1993). This variant is also reported in ClinVar (Variation ID: 15651), but is absent from the Genome Aggregation Database, indicating it is not a common polymorphism. The leucine at codon 30 is moderately conserved, and computational analyses predict that this variant is deleterious (REVEL: 0.910). In vitro studies show the variant protein is undetectable by various analyses, suggestive of an unstable hemoglobin variant (Hall 1993). Based on available information, this variant is considered to be pathogenic. References: Link to HbVar database: https://globin.bx.psu.edu/hbvar/menu.html de la Fuente-Gonzalo F et al. Study of three families with Hb Agrinio (alpha29(B10)Leu?Pro, CTG>CCG (alpha2)) in the Spanish population: three homozygous cases. Hemoglobin. 2012; 36(6):526-32. Hall G et al. A base substitution (T-->C) in codon 29 of the alpha 2-globin gene causes alpha thalassaemia. Br J Haematol. 1993; 85(3):546-52.
OMIM RCV000016937 SCV000037208 other HEMOGLOBIN AGRINIO 2022-09-12 no assertion criteria provided literature only
OMIM RCV000022605 SCV000043894 pathogenic Hemoglobin H disease, nondeletional 1998-05-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.